Persistent Asset Partners »

Moonlake Immunotherapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Moonlake Immunotherapeutics shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Moonlake Immunotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunotherapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunotherapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $57 61 0.94

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
UnitedHealth (UNH)
Regeneron Pharmaceuticals (REGN)
CVS Caremark Corporation (CVS)
Nebius Group Shs Class A (NBIS)
Pdd Holdings Sponsored Ads (PDD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Soleno Therapeutics (SLNO)
BioMarin Pharmaceutical (BMRN)
Labcorp Holdings Com Shs (LH)
Anthem (ELV)
Healthcare Services (HCSG)
Quest Diagnostics Incorporated (DGX)
Brightspring Health Svcs (BTSG)

View all positions for Persistent Asset Partners

Top funds holding Moonlake Immunotherapeutics

Simplex Trading
Group One Trading
Silverarc Capital Management
IMC-Chicago
Persistent Asset Partners

View all funds holding Moonlake Immunotherapeutics